Literature DB >> 11102410

Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG.

B Murugasu-Oei1, T Dick.   

Abstract

Depletion of oxygen triggers the shift-down of Mycobacterium bovis BCG to a state of dormancy. Bacilli in their dormant state are resistant to standard anti-mycobacterials. The nitroimidazole metronidazole was the first compound identified to show bactericidal activity against dormant tubercle bacilli. In contrast to metronidazole's selective toxicity for dormant bacilli, we report here that the nitrofurans nitrofurantoin, furaltadone and nitrofurazone showed bactericidal activity against dormant and growing bacteria. Importantly, the bactericidal effect of nitrofurans on dormant bacilli was 35- to 250-fold higher compared with metronidazole.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11102410     DOI: 10.1093/jac/46.6.917

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.

Authors:  C Boon; R Li; R Qi; T Dick
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  In vitro activities of mitomycin C against growing and hypoxic dormant tubercle bacilli.

Authors:  H L Peh; A Toh; B Murugasu-Oei; T Dick
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Mycobacterium bovis BCG response regulator essential for hypoxic dormancy.

Authors:  Calvin Boon; Thomas Dick
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

4.  Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.

Authors:  Sandra J Aedo; Juechun Tang; Mark P Brynildsen
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

5.  Compiling a molecular inventory for Mycobacterium bovis BCG at two growth rates: evidence for growth rate-mediated regulation of ribosome biosynthesis and lipid metabolism.

Authors:  D J V Beste; J Peters; T Hooper; C Avignone-Rossa; M E Bushell; J McFadden
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

6.  Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes.

Authors:  Gitte M Knudsen; Yin Ng; Lone Gram
Journal:  Appl Environ Microbiol       Date:  2013-09-20       Impact factor: 4.792

Review 7.  Modelling a Silent Epidemic: A Review of the In Vitro Models of Latent Tuberculosis.

Authors:  Savannah E R Gibson; James Harrison; Jonathan A G Cox
Journal:  Pathogens       Date:  2018-11-15

8.  Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery.

Authors:  Sean Ekins; Robert C Reynolds; Hiyun Kim; Mi-Sun Koo; Marilyn Ekonomidis; Meliza Talaue; Steve D Paget; Lisa K Woolhiser; Anne J Lenaerts; Barry A Bunin; Nancy Connell; Joel S Freundlich
Journal:  Chem Biol       Date:  2013-03-21

9.  Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach.

Authors:  Gavin J Ryan; Donald R Hoff; Emily R Driver; Martin I Voskuil; Mercedes Gonzalez-Juarrero; Randall J Basaraba; Dean C Crick; John S Spencer; Anne J Lenaerts
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

10.  A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.

Authors:  Julian G Hurdle; Robin B Lee; Nageshwar R Budha; Elizabeth I Carson; Jianjun Qi; Michael S Scherman; Sang Hyun Cho; Michael R McNeil; Anne J Lenaerts; Scott G Franzblau; Bernd Meibohm; Richard E Lee
Journal:  J Antimicrob Chemother       Date:  2008-08-07       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.